Affiliation:
1. Department of Pharmacy Practice NIPER‐Guwahati Guwahati Assam India
Abstract
AbstractSeveral preclinical studies have focused on the beneficial effects of garlic on cardiovascular diseases, but the results were inconsistent. We performed a systematic review and meta‐analysis on the effect of garlic powder tablets and aged garlic extract (AGE) in CAD patients, mainly focusing on blood pressure, coronary artery calcification, lipid profile, and inflammatory markers. We searched PubMed, Cochrane CENTRAL, and Google Scholar to identify randomized controlled trials which examined garlic's effect on CAD patients. The standardized mean difference with 95% CI was calculated using fixed‐effect or random‐effect models. Garlic has shown statistically significant changes of HDL (SMD = 0.18; 95% CI = −0.00 to 0.37; p = .05); LDL (SMD = −0.27; 95% CI = −0.46 to −0.08; p = .004), apolipoprotein‐A (SMD = 0.68; 95% CI = 0.24 1.13; p = .002), C‐RP (SMD = −0.59; 95% CI = −0.92 to −0.25; p = .0007), IL‐6 (SMD = −1.08; 95% CI = −2.17 to 0.01; p = .05), homocysteine (SMD = −0.66; 95% CI = −1.04 to −0.28; p = .0007) and CAC score (SMD = −1.61; 95% CI = −2.66 to −0.57; p = .003). In the case of subgroup analysis, the overall effect was significantly effective in reducing TC, LDL levels and improving HDL levels in CV risk patients. Our study findings provide consistent evidence that intake of garlic reduces CVD risk factors. However, garlic could be considered a safe natural medicine to debilitate inflammation in CAD patients.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献